Agilent to Acquire Proscia for $240M
Agilent Technologies has agreed to acquire pathology software maker Proscia for $240 million in cash. The deal includes up to $30 million in performance milestones, expanding Agilent into artificial intelligence diagnostics.
Agilent Technologies Inc will acquire pathology software maker Proscia for $240 million in cash, expanding its push into AI-enabled diagnostics. The deal includes up to $30 million tied to future performance targets. Proscia generated more than $18 million in revenue over the past 12 months.
The acquisition strengthens Agilent's pathology business and expands its presence in digital diagnostics. Privately held Proscia develops software that converts pathology slides into digital images for review and AI analysis. The companies have partnered since 2022 under a distribution agreement combining Agilent's pathology products with Proscia's software.
